Roundhill GLP-1 & Weight Loss ETF (OZEM): ETF
ETF traded on XNAS under symbol OZEM. Quoted in usd.
Roundhill Investments - GLP-1 & Weight Loss ETF
+0.76%$30.89
XNAS:OZEMEquity
AUM $56.44M·YTD --·Yield --
XNAS:OZEM$30.89+0.76%AUM $56.44MAbout OZEM
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.
Largest holdings
- LLY Eli Lilly & Co14.85%
- NVO Novo Nordisk A/S11.79%
- PFE Pfizer Inc7.92%
- KLRA Kailera Therapeutics Inc5.87%
- 1093.HK CSPC Pharmaceutical Group Ltd5.49%
- 4519.T Chugai Pharmaceutical Co Ltd5.04%
- AMGN Amgen Inc4.77%
- VKTX Viking Therapeutics Inc4.50%
- AZN AstraZeneca PLC4.37%
- 128940.KS Hanmi Pharm Co Ltd4.04%
Dividend History
Benchmark Comparison
Compared against
Performance Returns
Drawdown Chart
Analyst Coverage
Savings Plan Calculator
Total Invested
$70,000
Final Portfolio
$109,455
Total Return
+$39,455
(+56.4%)
Dividends Reinvested
$0
compounded into portfolio
Defaults are seeded from historical performance and trailing twelve-month yield. Past performance is not a forecast. Feel free to adjust any input to model your own assumptions.
ETF Key Metrics
AUM$56.44M
NAV$30.84
Premium/Discount+0.15%
Expense Ratio0.59%
Market Cap$50.13M
Shares Outstanding1.72M
Inception DateMay 21, 2024
Fund Details
IssuerRoundhill Investments
Asset ClassEquity
Beta0.41
SectorFinancial Services
DomicileUS
52-Week Range
$28.34$37.15
Current: $30.89
Volume
Volume3.47K
Avg Volume16.14K
Vol/Avg0.22x
30d
11.32K
60d
11.41K
90d
13.75K
Comparable ETFs